Longevity
Exclusive deal expands neurodegenerative diagnostics
NanoDetection secures global rights to antibody technology that may help distinguish Alzheimer’s from other brain diseases. A new licensing deal aims to bring greater precision to one of medicine’s biggest challenges: understanding what is happening inside the aging brain. Life science and diagnostics company NanoDetection Technology and New York-based biotech Oligomerix have announced an exclusive […] The post Exclusive deal expands neurodegenerative diagnostics appeared first on Longevity.Technology .
This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.
Read full coverage at Longevity.Technology →